BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15063812)

  • 1. Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function.
    Nishikimi T; Mori Y; Ishimura K; Tadokoro K; Yagi H; Yabe A; Horinaka S; Matsuoka H
    Am J Med; 2004 Apr; 116(8):517-23. PubMed ID: 15063812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M
    Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic peptides in patients with aortic stenosis.
    Qi W; Mathisen P; Kjekshus J; Simonsen S; Bjørnerheim R; Endresen K; Hall C
    Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
    Jarai R; Iordanova N; Jarai R; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K
    Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal proatrial natriuretic peptide and prognosis in patients with heart failure and preserved systolic function.
    Andersson B; Hall C
    J Card Fail; 2000 Sep; 6(3):208-13. PubMed ID: 10997746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between brain natriuretic peptide and coronary stenosis: influence of aging].
    Suzuki N; Mori H; Hazama M; Takahashi K; Moriya M; Yano K
    J Cardiol; 2004 Mar; 43(3):117-22. PubMed ID: 15067799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
    J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
    Wozakowska-Kapłon B; Opolski G
    Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of plasma atrial and brain natriuretic peptide levels during hemodialysis in hemodialysis patients with old myocardial infarction].
    Uetake S; Takahashi M; Tamano K; Honda T; Kobayashi T; Horinaka S
    J Cardiol; 2001 Aug; 38(2):61-71. PubMed ID: 11525111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass.
    Rubattu S; Sciarretta S; Ciavarella GM; Venturelli V; De Paolis P; Tocci G; De Biase L; Ferrucci A; Volpe M
    J Hypertens; 2007 Apr; 25(4):833-9. PubMed ID: 17351376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of left ventricular filling pattern on exercise-induced changes of natriuretic peptides in patients with suspected coronary artery disease.
    Møller JE; Bergeron S; Jaffe A; Pellikka PA
    Int J Cardiol; 2008 Feb; 124(2):204-10. PubMed ID: 17442418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence and severity of coronary artery disease and changes in B-type natriuretic peptide levels in patients with a normal systolic function.
    Kim BS; Lee HJ; Shin HS; Yoon JH; Lee HY; Kim BJ; Sung KC; Kang JH; Lee MH; Park JR
    Transl Res; 2006 Oct; 148(4):188-95. PubMed ID: 17002921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.
    Squire IB; Ørn S; Ng LL; Manhenke C; Shipley L; Aarsland T; Dickstein K
    J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of natriuretic peptides in patients with pulmonary thromboembolism.
    Kiely DG; Kennedy NS; Pirzada O; Batchelor SA; Struthers AD; Lipworth BJ
    Respir Med; 2005 Oct; 99(10):1286-91. PubMed ID: 16099151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro-brain natriuretic peptide used for the prediction of coronary artery stenosis.
    Wolber T; Maeder M; Rickli H; Riesen W; Binggeli C; Duru F; Ammann P
    Eur J Clin Invest; 2007 Jan; 37(1):18-25. PubMed ID: 17181563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels.
    Nakajima K; Onishi K; Dohi K; Tanabe M; Kurita T; Yamanaka T; Ito M; Isaka N; Nobori T; Nakano T
    Int J Cardiol; 2005 Oct; 104(3):332-7. PubMed ID: 16186065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.